It was reported that the health care provider requested review of device data to confirm device operation.Upon review, it was found that the self-conducted ventricular rhythm of the patient accelerated from the vt zone to the vf zone after anti-tachycardia pacing (atp) therapy was applied.The device then delivered three shocks.Following the first and second shocks the rhythm of this patient deteriorated into a ventricular fibrillation.The third shock successfully converted the rhythm.No additional adverse patient effects were reported.This device system remains in service.
|